Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Hepatol. Mar 18, 2017; 9(8): 427-435
Published online Mar 18, 2017. doi: 10.4254/wjh.v9.i8.427
Figure 1
Figure 1 Overall survival of liver transplant recipients, monitored for 15 years.
Figure 2
Figure 2 Kaplan-Meyer survival analysis reveals increased survival for patients younger than the median (53 years) (A), with body mass index lower than the median (24 kg/m2) (B) and hepatitis B as underlying disease (C).
Figure 3
Figure 3 Age and body mass index at the time point of transplantation were higher in deceased patients in comparison to patients who survived.
Figure 4
Figure 4 Kaplan-Meyer survival analysis reveals increased transplant survival for patients younger than the median (53 years) (A), with body mass index lower than the median (24 kg/m2) (B) and hepatitis B as underlying disease (C). BMI: Body mass index.
Figure 5
Figure 5 Percentage of survival in an age-matched control of the German general population (age range: 18-67 years). This age-matched control cohort was constructed baseding on historical data about the German healthy population (https://www.destatis.de).